🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting indeed. Very helpful #AMR resource 👇

The World Health Organization (WHO) released its first analysis of the antifungal pipeline. The findings are cause for concern: -4 new antifungals were approved in last 10 years -9 agents in clinical development against priority fungal pathogens - Antifungals with child-friendly formulations are lacking

UK health authorities sound alarm on Candida auris, noting annual upticks every year since 2020 manchestereveningnews.co.uk/news/health/uk… #AMR

Tremendous advances in cancer treatments have occurred in recent years, and patients are benefiting from immunotherapies, precision medicine, and other new technologies. That progress, however, is and will be increasingly eroded by superbugs. futureofpersonalhealth.com/infectious-dis… #AMR #Cancer

Nice reporting from The Washington Post that uses #LastofUs2 to explore the real-world challenges fungal infections pose and the difficulties of drug development washingtonpost.com/climate-enviro… #AMR

"Analysis of more than 106,000 bacterial isolates, 47% of which were from children under 2, found that resistance patterns varied across priority pathogens, with Escherichia coli showing 30% resistance to Access antibiotics..." via CIDRAP

Infections are a major cause of death among people with cancer. Read more about the ways in which #AMR is jeopardizing cancer care: futureofpersonalhealth.com/infectious-dis…

As CEO Henry Skinner cautioned in a STAT op-ed, the United States is ill-prepared to deal with the emerging crisis of fungal infections, from both clinical and policy perspectives statnews.com/2023/02/09/fun…

"If Europe can get the right pull incentives in place, I think it would send a strong message to investors and give an advantage to the small antimicrobial companies that are doing very good work and leading innovation across Europe." #AMR issuu.com/biocom/docs/eb…

In a new Infection Control Today Q&A, CEO Henry Skinner discussed the many ways in which #AMR is eroding the foundations of modern medicine and undercutting innovation in other therapeutic areas. infectioncontroltoday.com/view/broken-ma…

Carbapenem-resistant Acinetobacter baumannii (CRAB) accounted for more than 1/3 of all A baumannii infections from 2018 through 2022 and is increasingly more common, according to a new study cidrap.umn.edu/antimicrobial-… via CIDRAP #AMR

Thank you The Lancet for showcasing this important research on the risks #AMR pose to outpatients with #cancer. Learn more about the work of the Cancer and AMR Consortium 👇